LIPOSOME COMPOSITION FOR REDUCTION OF LIPOSOME INDUCED COMPLEMENT ACTIVATION
Application 1645/KOLNP/2005 published 2007-02-09, filed 2005-08-17
A method for reducing complement activation upon in vivo administration of a liposome preparation containing an entrapped therapeutic agent is described. The method involves providing liposomes having a polyethylene-glycol-derived neutral lipopolymer. (FIG). nil
Applicant
ALZA CORPORATION. AND YISSUM RESEARCH DEVELOPMENT COMPANY.,
1900 CHARLESTON ROAD, M 10-3, P.O.BOX 7210, MOUNTAIN VIEW, CA 94039-7210, USA. AND THE HEBREW UNIVERSITY OF JERUSALEM, ISRAEL, HI-TECH PARK, EDMOND J. SAFRA CAMPUS, P.O.BOX 39135, GIAT RAM, 91390 JERUSALEM , ISRAEL.
Inventor
ZALIPSKY, SAMUEL BARENHOLZ, YECHEZKEL
International Info
Classification: A61K
Publication Number: WO 04/078121
Application Date: 2004-02-26
Priority Information
60/451,362 USA 2003-02-28
60/524,176 USA 2003-11-21